News

MedPage Today4h
Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...
FDA lifts pause on Valneva’s chikungunya shot, but adds new limits
The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...
Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
MPR12h
FDA Lifts Valneva’s Chikungunya Vaccine Use Restriction in Older Adults
As part of a postmarketing requirement, Valneva will be initiating a study to assess the risk of severe chikungunya-like adverse reactions following administration of Ixchiq.
FDA lifts pause on Valneva's chikungunya vaccine in elderly
Valneva SE ( NASDAQ: VALN) said on Thursday that the FDA has lifted its pause on the use of its chikungunya vaccine, Ixchiq, ...
MedPage Today on MSN1d
FDA Lifts Pause on Chikungunya Vaccine in Older Adults, With Revised Labeling
"Based on the available data, and its benefit-risk assessment, FDA has removed the recommended pause in the use of Ixchiq in individuals 60 years of age and older," the agency said in a statement. The ...
FDA vaccine chief leaving agency after less than 3 months
Dr. Vinay Prasad is stepping down as the Food and Drug Administration’s top vaccine regulator after a brief tenure.
On Vaccines, Kennedy Has Broken Sharply With the Mainstream
While many officials and scientists embrace other parts of the secretary’s agenda, his stance on vaccines is alienating ...